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a b s t r a c t
CITED2 is a transcriptional co-factor with important roles in many organs of the developing mammalian
embryo. Complete deletion of this gene causes severe malformation of the placenta, and results in
signiﬁcantly reduced embryonic growth and death from E14.5. The placenta is a complex organ
originating from cells derived from three lineages: the maternal decidua, the trophectoderm, and the
extra-embryonic mesoderm. Cited2 is expressed in many of these cell types, but its exact role in the
formation of the placenta is unknown. Here we use a conditional deletion approach to remove Cited2
from overlapping subsets of trophectoderm and extra-embryonic mesoderm. We ﬁnd that Cited2 in
sinusoidal trophoblast giant cells and syncytiotrophoblasts is likely to have a non-cell autonomous role
in patterning of the pericytes associated with the embryonic capillaries. This function is likely to be
mediated by PDGF signaling. Furthermore, we also identify that loss of Cited2 in syncytiotrophoblasts
results in the subcellular mislocalization of one of the major lactate transporters in the placenta,
SLC16A3 (MCT4). We hypothesize that the embryonic growth retardation observed in Cited2 null
embryos is due in part to a disorganized embryonic capillary network, and in part due to abnormalities
of the nutrient transport functions of the feto-maternal interface.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The placenta is a complex organ that is essential for embryonic
development (reviewed in John and Hemberger, 2012). It provides
a link between embryonic and maternal blood circulatory systems,
and has an essential role in nutrient, gas and waste exchange. In
addition, it has important functions as a hormone signaling center,
as well as a source of hematopoeitic stem cells and immunomo-
dulatory molecules. It is comprised of cells derived from three
separate lineages: the maternal decidua, the trophectoderm, and
the extra-embryonic mesoderm. These cells are structured into
four layers. The decidual tissue is most proximal to the uterine
implantation site, and is separated from the main body of the
placenta by a layer of parietal trophoblast giant cells (TGC) derived
from the trophectoderm. Next lies the junctional zone that also
consists solely of trophectoderm-derived cells. Finally there is the
labyrinthine layer, which consists of a mixture of trophectoderm-
derived trophoblasts, and embryonic vessels derived from the
extra-embryonic mesoderm. It is within this layer that nutrient,
gas and waste exchange between the maternal and embryonic
circulatory systems occurs. In mice, the feto-maternal interface of
the labyrinthine layer consists of four layers of tightly-associated
cells (Enders, 1965). The embryonic vasculature is lined with
vascular endothelial cells (VECs), and the maternal sinuses
with mononuclear sinusoidal trophoblast giant cells (S-TGC).
In-between these cells are two layers of multi-nucleated syncytio-
trophoblasts. The elaborate branched structure of the embryonic
vessels and maternal sinuses in the labyrinthine layer forms after
the extra-embryonic allantois fuses with the trophectoderm-
derived chorion (reviewed in Arora and Papaioannou, 2012). Prior
to chorio-allantoic fusion, cells in the distal allantois differentiate
into VECs that coalesce to form endothelial tubes, and then
undergo remodeling to form the umbilical vessels. These vessels
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then invade the chorion, and undergo branching morphogenesis
(angiogenesis). When this process is complete, the ingressing
arterioles traverse the entire labyrinthine layer, before forming
an elaborate capillary mass extending back toward the base of the
placenta (Adamson et al., 2002; Rodriguez et al., 2004; Withington
et al., 2006). By contrast, the venules only penetrate a short way
into the labyrinthine layer, reaching up to meet the arteriole
capillaries. At the same time, ACTA2-positive vascular smooth
muscle cells also migrate from the allantois, and coat the larger
vessels. ACTA2-positive pericytes penetrate deeper into the pla-
centa, and form cores around which the arteriole capillary loops
are organized (Ohlsson et al., 1999).
In the placenta, angiogenesis is regulated in much the same
manner as elsewhere in the developing embryo (reviewed in
Chung and Ferrara, 2011). The most important growth factors
involved in this process are the platelet-derived growth factor
(PDGF)/vascular endothelial growth factor (VEGF) family. These
are secreted disulﬁde-linked proteins that bind to receptors of the
receptor tyrosine kinase (RTK) superfamily of proteins. There are
4 different PDGF proteins with two PDGF-speciﬁc receptors, and
5 VEGF proteins with three VEGF-speciﬁc receptors (Flt-1, KDR and
Flt-4) and an additional soluble form of Flt-1 (sFlt-1 or sVEGFR1).
These proteins have multiple roles in embryonic development, but
in placental angiogenesis VEGF secreted by the allantois and
labyrinthine stromal cells stimulates the migration and prolifera-
tion of VECs that express VEGF receptors (Arora and Papaioannou,
2012). By contrast, PDGF is expressed by VECs and PDGF receptors
by perivascular mesenchymal cells, and PDGF signaling is required
for pericyte recruitment, proliferation and differentiation (Jain,
2003; Ribatti et al., 2011). Genetic deletion of VEGF or VEGF
receptors results in loss of VECs in the allantois and/or placenta
(Ferrara et al., 1996; Shalaby et al.,1995), whereas loss of PDGF
signaling results in reduced numbers of placental pericytes, and
dilated embryonic capillaries (Bjarnegard et al., 2004; Ohlsson
et al., 1999).
CITED2 (CBP/p300-interacting transactivator, with Glu/Asp-rich
carboxy-terminal domain 2) is a multi-functional protein that is
widely expressed in embryonic and extra-embryonic tissues during
mammalian development, and in the adult (Barbera et al., 2002;
Dunwoodie et al., 1998; Weninger et al., 2005; Withington et al.,
2006). It has been the subject of intensive investigation over the past
few years, uncovering important roles in embryonic development,
embryonic and adult stem cells and the regulation of transcription and
signal transduction pathways. We and others have shown that
homozygous Cited2 null (Cited2ΔlacZ/ΔlacZ) embryos die around embryo-
nic day (E)14.5 (Bamforth et al., 2001; Barbera et al., 2002; Yin et al.,
2002). These embryos have a wide range of defects including disrup-
tions of left-right patterning, neural tube closure and heart formation
(Bamforth et al., 2001, 2004; Barbera et al., 2002; Lopes Floro et al.,
2011; Weninger et al., 2005; Yin et al., 2002). Conditional knockout
embryos that survive past E14.5 have revealed that Cited2 also plays a
role in the formation of a wide variety of tissues in more mature
embryos such as the liver, lung and eye (Chen et al., 2008, 2009; Qu
et al., 2007; Xu et al., 2008). Cited2 is also required for themaintenance
of quiescence of hematopoietic stem cells (Chen et al., 2007; Du et al.,
2012, 2014; Kranc et al., 2009) and for regulation of pluripotency and
differentiation in mouse embryonic stem cells (Li et al., 2012; Pritsker
et al., 2006). Despite these ﬁndings, there is no unifying model of
CITED2's mode of action, as it appears to act variously as: a transcrip-
tional activator (Bamforth et al., 2004; Glenn and Maurer, 1999; Tien
et al., 2004); a competitive inhibitor of transcription (Bhattacharya et
al., 1999; Yokota et al., 2003); or a modulator of protein acetylation
(Sakai et al., 2012). Therefore its requirement in each tissue or cell type
needs to be investigated individually. The placentas of complete Cited2
null (Cited2ΔlacZ/ΔlacZ) conceptuses are signiﬁcantly smaller than
Cited2þ /þ placentas from E12.5, and Cited2ΔlacZ/ΔlacZ embryos are
signiﬁcantly smaller two days later (E14.5) and die before birth
(Barbera et al., 2002). At E14.5, Cited2ΔlacZ/ΔlacZ placentas have fewer
differentiated trophoblast cell types, and their fetal vasculature is
disorganized (Withington et al., 2006). In particular, the capillaries at
the tips of the arterioles and venules are severely stunted, disorga-
nized and irregular in shape and thickness. By contrast, the maternal
blood spaces in Cited2ΔlacZ/ΔlacZ placentas only show minor defects,
with a slight increase in the size of sinusoids in some placentas.
Here we have used a conditional deletion approach to investi-
gate the role of Cited2 in embryonic capillary formation in the
developing placenta. We ﬁnd that Cited2 in S-TGC and syncytio-
trophoblasts is likely to have a non-cell autonomous role in
patterning of the pericytes associated with the embryonic capil-
laries. This function is likely to be mediated by PDGF signaling.
Furthermore, we also identify that loss of Cited2 in syncytiotro-
phoblasts results in the subcellular mislocalization of one of the
major lactate transporters in the placenta, SLC16A3 (MCT4). We
hypothesize that the embryonic growth retardation observed in
Cited2ΔlacZ/ΔlacZ embryos is due in part to a disorganized embryonic
capillary network, and in part due to abnormalities of the nutrient
transport functions of the feto-maternal interface.
Materials and methods
Mouse lines and genotyping
This research was performed following the guidelines, and with
the approval, of the Garvan Institute of Medical Research/St Vincent's
Animal Experimentation Ethics Committee, research approvals 09/33
and 12/33. Mouse lines carrying targeted alleles and randomly
inserted transgenes used in these studies are as follows: Cited2ΔlacZ
[Cited2tm1Jpmb] (Barbera et al., 2002), Cited2ﬂox [Cited2tm1.1Dunw] (Preis
et al., 2006), Tpbpa-Cre [Tg(Tpbpa-cre,–EGFP)5Jcc] (Simmons et al.,
2007); Tek-Cre [Tg(Tek-cre)12Flv] (Koni et al., 2001); Cyp19-Cre [Tg
(Cyp19a1-cre)5912Gle] (Wenzel and Leone, 2007); R26R [Gt(ROSA)
26Sortm1Sor] (Soriano, 1999); Z/EG [Tg(CAG-Bgeo/GFP)21Lbe/J] (Novak
et al., 2000). All mouse lines, with the exception of Cyp19-Cre and Z/EG,
were backcrossed for a minimum of ten generations into the C57BL/6J
genetic background, and were maintained on this background. The
Cyp19-Cre mouse line was backcrossed for ten generations into the
FVB genetic background, and was maintained on this background. The
Z/EGmouse line was backcrossed for 10 generations into the Quacken-
bush Swiss (Q(S)) genetic background, and was maintained on this
background. Mice and embryos were genotyped by PCR using the
following primers:
Cited2ΔLacZ 50-GACAACCCCCCCCAAATGACTGAC-30 and 50-GGCGAT-
GCCTGCTTGCCGAATATC-30; Cited2ﬂox 50-GTCTCAGCGTCTGCTCGTTT-30;
and 50-CTGCTGCTGTTGGTGATGAT-30; CYP19-Cre 50-GACCTTGCTGAGA-
TTAGATC -30 and 50-GAGAGAGAAGCATGTTTAGCTGGCC-30; Tpbpa-Cre
50-TCCAGTGACAGTCTTGATCCTTAAT-30 and 50-AAATTTTGGTGTACGGT-
CAGTAAAT-30; Tek-Cre 50-CATTTGGGCCAGCTAAACAT-30 and 50-ATTCT-
CCCACCGTCAGTACG-30; R26R 50-CACCAACGTAACCTATTCCA-30 and
50-TGTAGTCGGTTTATGCAGCA-30; Z/EG 50-CACCAACGTAACCTATTC-
CA-30 and 50-TGTAGTCGGTTTATGCAGCA-30.
Mice heterozygous for the Cited2ΔLacZ allele (Cited2ΔLacZ/þ) were
crossed with mice carrying with various Cre alleles. For Tpbpa-Cre
and Tek-Cre alleles, Cited2ΔLacZ/þ Creþ males were mated with
Cited2ﬂox/ﬂox females, generating three control genotypes: Cited2þ /ﬂox
Cre-; Cited2þ /ﬂox Creþ; Cited2ΔLacZ/ﬂox Cre-; and the conditionally
deleted genotype Cited2 ΔLacZ/ﬂox Creþ . For the Cyp19-Cre allele,
female double heterozygotes (Cited2ΔLacZ/þ Creþ) were mated
with Cited2ﬂox/ﬂox males, generating three control genotypes:
Cited2þ /ﬂox Cre-; Cited2þ /ﬂox Creþ; Cited2ΔLacZ/ﬂox Cre-; and the
conditionally deleted genotype Cited2ΔLacZ/ﬂox Creþ . Pups, embryos
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and placentas were collected at various stages of development,
and were weighed and genotyped.
Placental histological analysis
Placentas were harvested at E14.5, ﬁxed and sectioned in the
longitudinal plane. In all cases, sections from the central region of the
placenta (as judged by the umbilical attachment site) were examined
since this is where the morphology was well deﬁned and most
consistent. For ß-galactosidase staining and EGFP visualization, pla-
centas were ﬁxed in 1% paraformaldehyde for 4 hours at 4 1C. For
immunohistochemistry analysis, placentas were ﬁxed in 4% parafor-
maldehyde for 5 hours at 4 1C. Placentas were processed for cryo- and
parafﬁn sections as previously described (Rodriguez et al., 2004;
Withington et al., 2006) except for the antigen retrieval step on
parafﬁn sections which was performed by boiling sections in 10 mM
Tris HCl pH 9.0, 1 mM EDTA, 0.05% Tween 20 buffer for 20min. No
antigen retrieval was used on cryosections. To reduce autoﬂuores-
cence, parafﬁn sections were incubated in Sudan Black B as described
in (Viegas et al., 2007). The following reagents were used: rat
monoclonal anti-PECAM1 (#550274 BD Pharmigen, 1:200); mouse
monoclonal anti-α-smooth muscle actin (#M0851 clone1A4, Dako
Cytomation, 1:200); chicken polyclonal anti-ß-galactosidase (#AB9361
Abcam,1:100); rabbit polyclonal anti-ß-galactosidase (#A-11132Mole-
cular probes, 1:100); mouse monoclonal anti-ATP1A1, (Naþ/Kþ
transporting ATPase, alpha 1 polypeptide, clone alpha 6F, Develop-
mental Studies Hybridoma Bank, 1:20); chicken polyclonal anti-
Monocarboxylate Transporter 1 (SLC16A1, #AB1286-I Merck Millipore,
1:200); rabbit polyclonal anti-Monocarboxylate Transporter 4
(SLC16A3, #AB3314P Merck Millipore, 1:200); rabbit polyclonal anti-
PDGFB (H-55 #7878 Santa Cruz, 1:50); rabbit polyclonal anti-PDGFRβ
(968, #sc432 Santa Cruz, 1:50); rabbit polyclonal anti-GLUT1 (SLC2A1,
NB110-39113 Novus Biologicals, 1:200); Isolectin GS-IB4 from Griffonia
simplicifolia conjugated with Alexa Fluors 488 (#l21411 Molecular
probes 1:200) or Alexa Fluors 568 (l21412 Molecular Probes 1:200);
40,6-Diamidino-2-phenylindole dihydrochloride (DAPI #D9542 Sigma-
Aldrich, 1:1000); TO-PROs-3 (Invitrogen 1:1000); Hoechst 33258
(#3569 Invitrogen 1:1000). Donkey secondary antibodies raised
against chicken, rabbit, rat or mouse and conjugated to ﬂuorophores
DyLight649, Alexa Fluors488, Alexa Fluors549, or DyLight 405 were
purchased from Jackson ImmunoResearch. Images were captured on a
Carl Zeiss LSM 7 Duo confocal microscope.
Quantitative analysis
Quantitative analysis was performed using the ImageJ version
1.48a software (National Institutes of Health). For capillary lumen
cross-sectional area, longitudinal placental sections from three pla-
centas were analyzed for each genotype. Individual sections were
immunostained with an anti-PECAM1 antibody, and three randomly
chosen ﬁelds for each section (encompassing the fetal capillaries) were
imaged with a 20 objective. The lumen cross-sectional area of every
capillary visible (60 per ﬁeld) was selected using theWand tool, and
measured. Values were averaged for each placenta, the mean and
standard error were calculated for each genotype and area relative to
Cited2þ /ΔlacZ was plotted. For MCT1 and MCT4 quantitation, long-
itudinal placental sections from three placentas were analyzed for
each genotype and for GLUT1 sections, from four placentas were
analyzed. Individual sections were co-stained with an anti-MCT1
antibody, and either anti-MCT4 or anti-GLUT1 antibodies, and three
(two for GLUT1) randomly chosen ﬁelds for each section (encompass-
ing the fetal capillaries) were imaged with a 20x objective. Fluores-
cence intensity was adjusted equally in all images using the same
threshold value to remove non-speciﬁc background staining. For each
protein, total staining area was measured. Values were averaged for
each placenta, the mean and standard error were calculated for each
genotype and staining area relative to Cited2þ /ΔlacZ was plotted. For
PDGFRß quantitation, longitudinal placental sections from three
placentas were analyzed for each genotype. Individual sections were
immunostained with anti-PDGFRß and anti-ACTA2 antibodies, and
three randomly chosen ﬁelds for each section (encompassing the fetal
capillaries) were imaged with a 20 objective. Fluorescence intensity
in the PDGFRß and ACTA2 channels were adjusted equally in all
images using the same threshold value to remove non-speciﬁc back-
ground staining. To determine the intensity of PDGFRß staining in
ACTA2-positive cells, the thresholded ACTA2 channel was binarized,
the Image Calculator “multiply” function was used on the binarized
ACTA2 and thresholded PDGFRß channels, and the relative PDGFRß
staining per pixel measured. To determine the intensity of staining in
the ACTA2-negative cells, the binarized ACTA2 channel was inverted,
and the same process repeated. Values were averaged for each
placenta, the mean and standard error calculated for each genotype,
and mean staining intensity relative to Cited2þ /ΔlacZ was plotted. For
PDGFB quantitation, longitudinal placental sections from three pla-
centas were analyzed for each genotype. Individual sections were
immunostained with an anti-PDGFB antibody, and three randomly
chosen ﬁelds for each section (encompassing the fetal capillaries) were
imaged with a 20 objective. Fluorescence intensity was adjusted
equally in all images using the same threshold value to remove non-
speciﬁc background staining, and then the relative PDGFB staining per
pixel was measured. Values were averaged for each placenta, the
mean and standard error calculated for each genotype, and staining
intensity relative to Cited2þ /ΔlacZ was plotted. For each analysis,
statistical signiﬁcance was calculated using one-way analysis of
variance (ANOVA) with Tukey's post-hoc test. For capillary cross-
sectional area, prior to analysis by ANOVA the data were transformed
using natural logarithms to correct for skew.
Results
Cited2ΔlacZ/ΔlacZ placentas have disorganized pericytes
and enlarged capillaries
Previously we have shown an alteration in the protein expres-
sion pattern of the vascular smooth muscle cell and pericyte
marker α smooth muscle actin (ACTA2) in Cited2ΔlacZ/ΔlacZ placen-
tas prior to the advent of reduced weight (Withington et al., 2006).
However these studies did not show precise details of the altered
placental morphology. Therefore we re-evaluated the distribution
of vascular endothelial cells (PECAM1-positive) and pericytes
(ACTA2-positive) within the placental labyrinthine zone of
Cited2þ /þ , Cited2þ /ΔlacZ and Cited2ΔlacZ/ΔlacZ E14.5 placentas using
immunoﬂuorescence and confocal microscopy. At this stage of
placental development, ACTA2-positive pericytes are arranged in
core-like structures around which the fetal capillaries are orga-
nized (Ohlsson et al., 1999). At low magniﬁcation there was no
clear difference in the overall expression levels of either protein
between genotypes (Fig. S1). We next examined magniﬁed views
of embryonic vessels at three different positions within the
labyrinthine layer. Large vessels at the base of the placenta
(Fig. S2), and medium sized vessels in the middle of the labyr-
inthine layer (Fig. S3), both showed no difference in PECAM1 or
ACTA2 expression level or pattern between genotypes. By contrast,
the ACTA2-positive pericytes adjacent to the embryonic capillaries
were disorganized and had reduced ACTA2 expression in Cite-
d2ΔlacZ/ΔlacZ placentas (Fig. 1E–H) compared to Cited2þ /þ (not
shown) and Cited2þ /ΔlacZ placentas (Fig. 1A–D). In addition,
PECAM1 staining followed by quantitation of capillary lumen
cross-sectional area revealed that these capillaries were signiﬁ-
cantly enlarged in the Cited2ΔlacZ/ΔlacZ E14.5 placentas compared to
those of Cited2þ /ΔlacZ placentas (Fig. S4A), in keeping with our
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previous observations using fetal vascular resin casts of E14.5
Cited2ΔlacZ/ΔlacZ placentas (Withington et al., 2006).
Conditional deletion of Cited2 in subsets of placenta cells results in
decreased placenta and embryo weight, but does not affect embryo
survival
Cited2 is expressed in many different types of cell within the
placenta, including both mesoderm- and trophectoderm-derived cells.
We therefore used a conditional deletion strategy to determine in
which cell type(s) Cited2was required for patterning of the embryonic
capillaries. The Cited2ΔlacZ allele is expressed in endothelial cells of the
fetal vasculature (Withington et al., 2006). We therefore used the Tek-
Cre transgene to determine if Cited2was required within these cells for
placental patterning. This allele drives expression of Cre recombinase
in all vascular endothelial cells (VECs) from E7.5 in both embryonic
and extra-embryonic vessels, including those of the yolk sac and
placenta (Constien et al., 2001; Koni et al., 2001; Tang et al., 2004). It is
also expressed in hematopoietic cells. We crossed Cited2ΔlacZ/þ
Tek-Creþ males with Cited2ﬂox/ﬂox females and collected, weighed
Fig. 1. Comparison of vascular endothelial cell and smooth muscle cell markers in fetal capillaries of Cited2ΔlacZ/þ , Cited2ΔlacZ/ΔlacZ and conditionally deleted placentas.
Representative longitudinal cryosections of (A–D) Cited2ΔlacZ/þ (Het), (E–H) Cited2ΔlacZ/ΔlacZ (Null), (I–L) Cited2ΔlacZ/ﬂox; Tek-Creþ , (M–P) Cited2ΔlacZ/ﬂox; Tpbpa-Creþ and (Q–T)
Cited2ΔlacZ/ﬂox; Cyp19-Creþ E14.5 placentas stained with PECAM1 (A,E,I,M,Q) and ACTA2 (B,F,J,N,R). (C,G,K,O,S) Merged images with nuclei stained with TO-PRO-3 (blue). (D,H,
L,P,T) Magniﬁed views of the boxed areas. Total number of placentas examined: Cited2þ /þ n¼4 (not shown), Cited2ΔlacZ/þ n¼7, Cited2ΔlacZ/ΔlacZ n¼9, Tek-Cre n¼9, Tpbpa-Cre
n¼5 and Cyp19-Cre n¼5. The scale bar represents 50 μm in panels A–O, and 13 μm in the magniﬁed views.
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and genotyped mice and placentas at various developmental stages
from E14.5 to birth. In contrast to Cited2ΔlacZ/ΔlacZ (Withington et al.,
2006), deletion of Cited2 with the Tek-Cre allele had no effect on
embryo or pup survival (Table S1). However conditionally deleted
placentas were signiﬁcantly smaller than controls at E16.5 (Fig. 2A)
and conditionally deleted embryos were smaller than controls at E18.5
(Fig. 2B). Cited2 is broadly expressed in many trophoblast cell types.
We next used the Tpbpa-Cre transgene (Simmons et al., 2007) to delete
Cited2 from a subset of these cells. This transgene is active from E8.5,
with recombinase activity evident in spongiotrophoblasts, some
trophoblast giant cells (TGCs: spiral artery-TGCs, canal-TGCs and
parietal-TGCs), but not in sinusoidal-TGCs or labyrinthine syncytiotro-
phoblasts (Hu and Cross, 2011; Simmons et al., 2007). We crossed
Cited2ΔlacZ/þ Tpbpa-Creþ males with Cited2ﬂox/ﬂox females and
collected mice and placentas at various developmental stages from
E14.5 to birth. Deletion of Cited2 from Tpbpa-Cre expressing tropho-
blasts had no effect on embryo or pup survival (Table S1), however
conditionally deleted placentas were signiﬁcantly smaller than con-
trols from E16.5 (Fig. 2C) and conditionally deleted pups were smaller
than controls at P0 (Fig. 2D). We next conditionally deleted Cited2
from a broader range of derivatives of trophoblast stem cells, including
spongiotrophoblasts, labyrinthine trophoblasts and some secondary
TGC, using the Cyp19-Cre transgene (Wenzel and Leone, 2007). The
Cyp19-Cre transgene shows the strongest and most stable expression
when inherited through the maternal line (Wenzel and Leone, 2007),
thus for experiments using this transgene we crossed Cited2ΔlacZ/þ
Cyp19-Creþ females with Cited2ﬂox/ﬂox males and collected mice and
placentas at various developmental stages from E14.5 to birth.
Fig. 2. Conditional deletion of Cited2 affects placental and embryo weight. Graphs showing normalized weights of (A) Tek-Cre E16.5 placentas, (B) Tek-Cre E18.5 embryos, (C)
Tpbpa-Cre E16.5 placentas, (D) Tpbpa-Cre P0 pups, (E) Cyp19-Cre E14.5 placentas and (F) Cyp19-Cre E16.5 embryos. Error bars indicate standard deviations. Student's t-test
was used to compare the weights of conditionally deleted embryos and placentas to those of the three control genotypes. n po0.05, nn po0.01, nnn po0.001. C2f/þ
Cre-, C2f/þ Creþ and C2f/C2Δ Cre- represent the three control genotypes; and C2f/C2Δ Creþ represents conditionally deleted embryos.
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Deletion of Cited2 from Cyp19-Cre expressing trophoblasts had no
effect on embryo or pup survival (Table S1), however conditionally
deleted placentas were signiﬁcantly smaller than controls at E14.5
(Fig. 2E) and conditionally deleted embryos were signiﬁcantly smaller
than controls at E16.5 (Fig. 2F). These results suggest that Cited2 may
be required in multiple cell types for correct formation of the placenta.
However since the time of onset of placental and embryonic growth
restriction is earliest in the Cyp19-Cre conditional deletion, then the
most important function of Cited2 is most likely to be in trophoblasts.
Conditional deletion of Cited2 using Cyp19-Cre and Tek-Cre partially
recapitulates the placental phenotype of the Cited2ΔlacZ/ΔlacZ
We next examined the placental phenotypes present in con-
ditionally deleted placentas at the molecular level. We compared
the distribution of vascular endothelial cells (PECAM1) and peri-
cytes (ACTA2) within the placental labyrinthine zone of condi-
tionally deleted E14.5 placentas to those of Cited2þ /þ (not shown),
Cited2ΔlacZ/þ (Fig. 1A–D) and Cited2ΔlacZ/ΔlacZ (Fig. 1E–H) placentas.
In Tpbpa-Cre deleted placentas the capillary lumen cross-sectional
area was similar in size to those in Cited2þ /þ or Cited2þ /ΔlacZ
placentas (Fig. S4A), and the arrangement of ACTA2-positive
pericytes was essentially the same (Fig. 1M–P). By contrast, in
Cyp19-Cre deleted placentas the capillary lumen cross-sectional
area was signiﬁcantly increased (Fig. S4A), and the ACTA2-positive
pericytes were more sparse and less well organized (Fig. 1Q–T).
Overall the Cyp19-Cre deleted placentas appeared very similar to
Cited2ΔlacZ/ΔlacZ placentas. Interestingly, the Tek-Cre deleted pla-
centas showed an intermediate phenotype, with considerable
variation between individual placentas: 4/9 Tek-Cre placentas were
similar to Cited2ΔlacZ/ΔlacZ (Fig. 1I–L), 2/9 had an intermediate
phenotype (not shown) and 3/9 were similar to Cited2ΔlacZ/þ
placentas (Fig. 1A–D). Due to the great variation in the phenotype
of individual placentas, capillary lumen cross-sectional area was
not quantiﬁed for this line. These results conﬁrm that the most
important placental function of Cited2 at E14.5 is in Cyp19-Cre
expressing trophoblasts.
The Cited2ﬂox allele Is more broadly deleted than expected
Since deletion of Cited2 by each transgene gave a different
phenotype, and each of the three Cre transgenes is expressed in a
partially overlapping subset of placental labyrinthine cells, we next
sought to use this information to determine exactly which cells in
the labyrinthine layer were responsible for the phenotype of
Cited2ΔlacZ/ΔlacZ. Previously the expression of each of the Cre trans-
genes has been described by use of the R26R reporter mouse line.
This line only produces cytoplasmic ß-galactosidase protein in cells
in which Cre recombinase activity is present, or in cells that have
been derived from these (Soriano, 1999). However it is well known
that the efﬁciency of deletion of different ﬂoxed loci can vary
(Vooijs et al., 2001). Therefore we made use of the LacZ gene in the
Cited2ﬂox allele to conﬁrm that all three Cre lines were deleting
Cited2 in the previously reported patterns. We designed the
Cited2ﬂox allele such that when the Cited2 coding region is deleted
by Cre recombinase, it is replaced by an in-frame nuclear LacZ
coding region (nLacZ) under the transcriptional control of the
Cited2 promoter (Preis et al., 2006). Thus, with this reporter
ß-galactosidase will only be expressed in the nucleus of cells where:
(1) Cre has been expressed; and (2) the Cited2 locus is currently
transcriptionally active. To test the Tek-Cre and Tpbpa-Cre alleles, we
crossed Creþ males with either R26R or Cited2ﬂox/ﬂox females, and
for the Cyp19-Cre allele, we crossed Creþ females with R26R or
Cited2ﬂox/ﬂox males. Creþ; Cited2ﬂox/þ and Creþ; R26Rþ /- placentas
were collected at E14.5, ﬁxed, cryosectioned and stained for ß-
galactosidase activity. For each of the three Cre alleles, there was
clearly more ß-galactosidase activity detectable from the Cited2ﬂox
allele than from the R26R locus (Fig. S5). Surprisingly, in each case
ß-galactosidase activity from the Cited2ﬂox allele was also present in
a much broader domain than that expressed from the R26R locus.
For example, deletion of Cited2 by the Tek-Cre allele occurred in the
junctional zone (Fig. S5A, arrow) and in non-VECs in the labyrinth
(Fig. S5B, arrowheads), and Tpbpa-Cre deleted Cited2 in the labyr-
inthine layer (Fig. 5H) in addition to the junctional zone (Fig. S5G,
arrow). This could indicate that either the R26R locus is not well
expressed in the placenta, or that the Cited2ﬂox allele is ectopically
expressing ß-galactosidase. To distinguish between these possibi-
lities, we repeated our deletion analysis using a third reporter allele
Z/EG (Novak et al., 2000). This reporter allele ubiquitously expresses
lacZ but Cre excision removes the lacZ gene, activating expression of
a second reporter, EGFP. This locus is integrated just upstream of the
Rasa4 gene on mouse chromosome 5 (Colombo et al., 2010), and its
expression is driven by the chicken ß-actin promoter with upstream
(pCAGGS) enhancer elements. Thus it is completely independent of
the R26R promoter. To test the Tek-Cre and Tpbpa-Cre alleles with
this reporter, we crossed Creþ males with Z/EGþ females, and for
the Cyp19-Cre allele, we crossed Creþ females with Z/EGþ males.
Creþ; Z/EGþ placentas were collected at E14.5, ﬁxed, cryosectioned
and imaged for EGFP expression. For each of the three Cre alleles,
the pattern of EGFP reporter gene expression was similar to the
pattern of ß-galactosidase activity detectable from the Cited2ﬂox
allele, rather than that from the R26R locus (Fig. S5C,D,I,J,O,P). This
supports the conclusion that the R26R locus is not expressed in all
placental cell types.
Conﬁrmation of the identity of Cited2 deleted cells for each Cre allele
We next used a combination of gross morphology and immu-
nohistochemistry to precisely determine in which cells Cited2ﬂox
was deleted by each Cre allele (results summarized in Table 1).
Table 1
A summary of Cited2ﬂox and R26R ß-galactosidase reporter gene expression after Cre-mediated deletion.
Cre line Reporter Trophoblasts Vasculature
TGC SpT GlyT SynT-I SynT-II EC PC
P Spa C S
Tek-Cre R26R – – – – – – – – þþþ –
Cited2ﬂox þþ – þþ þþþ þþ þþ þ 7 – –
Tpbpa-Cre R26R 7 þþ 7 – þþ þþþ – – – –
Cited2ﬂox þþþ þ þþ 7 þþ þþ þ – – þþþ
Cyp19-Cre R26R þþ þ þþ þþ þþ þþ þþ þþ – –
Cited2ﬂox þþþ þ þþ þþ þþþ þþþ þþ þþ – 7
TGC¼trophoblast giant cell; P¼parietal TGC; Spa¼spiral artery TGC; C¼canal TGC; S¼sinusoidal TGC; SpT¼spongiotrophoblast cells; GlyT¼glycogen trophoblast cells;
SynT-I¼syncytiotrophoblast layer I; SynT-II¼syncytiotrophoblast layer II; EC¼endothelial cell; PC¼pericyte.
J.L.M. Moreau et al. / Developmental Biology 392 (2014) 62–79 67
Given the major phenotypic effect of Cited2 deletion in the
placenta was a disruption of embryonic capillary formation, we
focused our attention on the labyrinthine layer. To test the Tek-Cre
and Tpbpa-Cre alleles, we crossed Creþ males with Cited2ﬂox/ﬂox
females, and for the Cyp19-Cre allele, we crossed Creþ females
with Cited2ﬂox/ﬂox males. Placentas were collected at E14.5, ﬁxed
and parafﬁn sectioned. Immunostaining of ß-galactosidase protein
in parafﬁn sections (Fig. 3) was consistent with ß-galactosidase
activity in cryosections (Fig. S5). Sinusoidal TGC line the maternal
blood spaces, and are easily identiﬁed by their large nuclei (Fig. 3,
indicated by asterisks). In both Tek-Cre (Fig. 3A–D) and Cyp19-Cre
(Fig. 3I–L), all S-TGC were positive for ß-galactosidase, although
staining intensity varied considerably between individual S-TGC in
the Cyp19-Cre line. By contrast, only half of the S-TGC in Tpbpa-Cre
placentas were positive for ß-galactosidase (Fig. 3E–H). Staining of
placental sections with isolectin GS-IB4 from Griffonia simplicifolia
(IB4) to mark vascular endothelial cells lining the embryonic
vasculature revealed that high levels of ß-galactosidase were also
present in some of the small cells situated between the maternal
blood spaces and the embryonic vasculature (Fig. 3, indicated by
arrows). These cells are syncytiotrophoblasts that are organized
into two layers, with SynT-I cells adjacent to the S-TGC lining the
maternal blood spaces and SynT-II cells adjacent to the VEC layer
lining the embryonic vasculature (Enders, 1965; Hernandez-
Verdun, 1974). These cells can be distinguished by immunostain-
ing for SLC16A1 (also called MCT1, expressed at the apical
membrane of SynT-I) and SLC16A3 (also called MCT4, expressed
on the basal membrane of SynT-II; (Nagai et al., 2010)). Placentas
for all three Cre crosses were co-stained for ß-galactosidase,
MCT1 and a membrane marker (Naþ/Kþ transporting ATPase,
(Mobasheri et al., 2001); Fig. 4). In all three cases, ß-galactosidase
was clearly present in SynT-I cells (Fig. 4, SynT-I nuclei indicated
by arrows). By contrast, co-staining with ß-galactosidase, MCT4
and ATPase revealed that ß-galactosidase was only expressed in
SynT-II cells in placentas from the Tek-Cre and Cyp19-Cre crosses
(Fig. 5, SynT-II nuclei indicated by arrows). Next we co-stained
placentas for all three Cre crosses for ß-galactosidase and the
pericyte marker ACTA2 (Fig. 6). Surprisingly, ß-galactosidase was
clearly apparent in all pericytes in placentas from the Tpbpa-Cre
cross (Fig. 6E–H), and 50% of those from the Cyp19-Cre cross
(Fig. 6I–L), but completely absent from those from the Tek-Cre
cross (Fig. 6A–D). Finally we also examined ß-galactosidase
expression in the junctional and decidual layers of the placenta
and found that ß-galactosidase was also expressed in spongiotro-
phoblasts, glycogen trophoblasts and parietal TGC in all three Cre
crosses; and in spiral artery trophoblasts in Tpbpa-Cre and Cyp19-
Cre crosses (Table 1; data not shown).
Deletion of Cited2 in syncytiotrophoblasts affects MCT4 protein
expression
The capillary phenotype was present to varying degrees in both
Cyp19-Cre and Tek-Cre deleted placentas, but not in Tpbpa-Cre
deleted placentas. The only cells in which Cited2 is expressed in
Cited2þ /þ and Tpbpa-Cre placentas, but is deleted in Cyp19-Cre
and Tek-Cre, are SynT-II and some S-TGC. Thus we hypothesized
that the expression of Cited2 in these cells might be required for
correct capillary patterning. We therefore compared the expres-
sion of molecular markers in syncytiotrophoblasts between
Cited2þ /þ , Cited2ΔlacZ/þ , Cited2ΔlacZ/ΔlacZ and conditionally deleted
Fig. 3. Comparison of ß-galactosidase expressing cells with vascular endothelial cells in Cited2 conditionally deleted placentas. Representative longitudinal parafﬁn sections
of (A–D) Cited2ﬂox/þ; Tek-Creþ , (E–H) Cited2ﬂox/þ; Tpbpa-Creþand (I–L) Cited2ﬂox/þ; Cyp19-Creþ E14.5 placentas. (A,E,I) ß-galactosidase (red) and TO-PRO-3 (blue) staining.
(B,F,J) The same sections stained with ß-galactosidase (red) and isolectin B4 (IB4, green). (C,G,K) Merged images. (D,H,L) Schematic representation of the boxed areas in
panels D,H,L showing the organization of fetal blood vessels (fbv), sinusoidal-TGC (asterisks) and syncytiotrophoblast layers (arrows). Total number of placentas examined:
Tek-Cre n¼4, Tpbpa-Cre n¼4 and Cyp19-Cre n¼4. The scale bar represents 50 μm in immunoﬂuorescence panels and 13 μm in schematic panels.
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E14.5 placentas for each of the Cre alleles. We intercrossed
Cited2ΔlacZ/þ males and females to produce Cited2þ /þ , Cite-
d2ΔlacZ/þ and Cited2ΔlacZ/ΔlacZ placentas; for the Tek-Cre and
Tpbpa-Cre lines we crossed Cited2ΔlacZ/þ Creþ males with Cited2-
ﬂox/ﬂox females; and for the Cyp19-Cre line we crossed Cited2ΔlacZ/þ
Creþ females with Cited2ﬂox/ﬂox males. E14.5 placentas were
collected, ﬁxed and parafﬁn sections immunostained using anti-
MCT1 and anti-MCT4 antibodies (Fig. 7). There were no obvious
differences in the expression levels or pattern of MCT1 between
any of the samples, suggesting that SynT-I cells were unaffected by
deletion of Cited2. This was conﬁrmed by quantiﬁcation of the
staining area of MCT1 in Cited2ΔlacZ/þ , Cited2ΔlacZ/ΔlacZ, Tpbpa-Cre
and Cyp19-Cre lines (Fig. S4B). Tek-Cre placentas were not quanti-
ﬁed due to their potentially variable phenotype (see below). By
contrast, the subcellular localization of MCT4 was clearly altered in
the Cited2ΔlacZ/ΔlacZ (Fig. 7E–H) and Cyp19-Cre conditionally deleted
placentas (Fig. 7Q–T), compared to Cited2þ /þ (not shown), Cite-
d2ΔlacZ/þ (Fig. 7A–D) and Tpbpa-Cre conditionally deleted placen-
tas (Fig. 7M–P). Tek-Cre placentas had an intermediate phenotype
with 3/4 placentas similar to Cited2ΔlacZ/ΔlacZ (Fig. 7I–L) and 1/4
similar to Cited2þ /þ (not shown). Instead of the normal sharp cell-
surface expression of MCT4 (Fig. 7D and P, indicated by arrows),
SynT-II cells in Cited2ΔlacZ/ΔlacZ and Cyp19-Cre and Tek-Cre con-
ditionally deleted placentas showed broad MCT4 expression
throughout the cytoplasm (Fig. 7H,L,T, indicated by arrowheads).
Quantiﬁcation conﬁrmed a signiﬁcant increase of the MCT4 stain-
ing area in Cited2ΔlacZ/ΔlacZ and Cyp19-Cre placentas compared to
Cited2ΔlacZ/þ (Fig. S4C). Tek-Cre placentas were not quantiﬁed due
to their variable phenotype. Thus altered MCT4 expression was
only detected in placentas with the capillary phenotype described
above. We next sought to determine if the altered localization of
MCT4 was limited to this protein, or reﬂected a more general
perturbation of protein sorting to the membrane in SynT-II cells.
MCT1 and MCT4 are the major lactate transporters expressed in
the murine placenta (Nagai et al., 2010). Another transporter
protein expressed in SynT-II cells is SLC2A1 (also known as GLUT1,
Nagai et al., 2010). In contrast to MCT4, this protein is symme-
trically expressed, being present on both apical and basal mem-
branes of SynT-II. We immunostained cryosections from the same
placentas described above with anti-GLUT1 and anti-MCT1 anti-
bodies (Fig. S6). There were no obvious differences in the expres-
sion levels or pattern of GLUT1 between any of the samples. This
was conﬁrmed by quantiﬁcation of the staining area of GLUT1 in
Cited2ΔlacZ/þ , Cited2ΔlacZ/ΔlacZ, Tpbpa-Cre and Cyp19-Cre lines (Fig.
S4D). Tek-Cre placentas were not quantiﬁed due to their poten-
tially variable phenotype. This suggests that deletion of Cited2 did
not broadly affect protein sorting to the membrane of SynT-II cells.
Deletion of Cited2 results in altered expression of PDGFRß
and PDGFB proteins
Loss of either PDGFB ligand or the PDGFRß receptor in mouse
embryos results in a similar fetal capillary phenotype to that of
Cited2ΔlacZ/ΔlacZ (Bjarnegard et al., 2004; Ohlsson et al., 1999). We
therefore compared the expression of these proteins between
Cited2þ /þ , Cited2ΔlacZ/þ , Cited2ΔlacZ/ΔlacZ and conditionally deleted
Fig. 4. Comparison of ß-galactosidase expressing cells with SynT-I cells in Cited2 conditionally deleted placentas. Representative longitudinal parafﬁn sections of (A–D)
Cited2ﬂox/þ; Tek-Creþ , (E-H) Cited2 Cited2ﬂox/þ; Tpbpa-Creþand (I–L) Cited2ﬂox/þ; Cyp19-Creþ E14.5 placentas. (A,E,I) ß-galactosidase (white) and MCT1 (green) staining. (B,F,
J) The same sections stained with MCT1 (green), ATPase (red) and Hoechst 33258 (blue). (C,G,K) Merged images. (D,H,L) Schematic representation of the boxed areas in
panels D,H,L showing the apical membrane of the SynT-I layer (green) facing the maternal sinusoids (ms), sinusoidal TGC (asterisks), and SynT-I nuclei (arrows).
Total number of placentas examined: Tek-Cre n¼4, Tpbpa-Cre n¼4 and Cyp19-Cre n¼4. The scale bar represents 50 μm in immunoﬂuorescence panels and 25 μm
in schematic panels.
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E14.5 placentas for each of the Cre alleles. Previous reports suggest
that in the placenta PDGFRß is expressed in pericytes and some
trophoblasts (probably S-TGC), whereas PDGFB is expressed in
VECs (Chhabra et al., 2012; Ohlsson et al., 1999). We sought to
more precisely identify which placental cells expressed PDGFRß
and PDGFB proteins in the placental labyrinth using immunoﬂuor-
escence (Fig. S7). Firstly, cryosections of E14.5 Cited2þ /þ and
Cited2ΔlacZ/þ placentas were stained for PDGFRß, PECAM1 and
MCT1 (Fig. S7A–E). PDGFRß was not expressed in either VECs (Fig.
S7C0, arrow) or SynT-I (Fig. S7E0, arrowhead). However expression
was clearly present in both S-TGC (Fig. S7E0, asterisk) and pericytes
(Fig. 8C, arrow). Next, cryosections of E14.5 Cited2þ /þ and Cite-
d2ΔlacZ/þ placentas were stained for PDGFB, PECAM1 and MCT1
(Fig. S7F–J). PDGFB was clearly expressed in VECs (Fig. S7H0,
arrow), but was also present between VECs and SynT-I cells (Fig.
S7J0, circle), most likely in SynT-II cells. High levels of PDGFB were
also apparent in S-TGC (Fig. S7J0, asterisk), but not pericytes (not
shown). To compare the expression levels of PDGFRß between
E14.5 placentas of all genotypes, cryosections were stained for
PDGFRß, ACTA2 and MCT1 (Fig. S8, magniﬁed views in Figs. 8 and
9). PDGFRß appeared to be expressed at equivalent levels in
ACTA2-positive pericytes in all placentas regardless of their
genotype. This was despite the reduced number and poor organi-
zation of these cells in Cited2ΔlacZ/ΔlacZ and Cyp19-Cre and Tek-Cre
conditionally deleted placentas (Fig. 8). This was conﬁrmed by
quantitation of the PDGFRß staining intensity in ACTA2-positive
cells in sections from three placentas from each genotype
(Fig. S4E). The Tek-Cre placentas were not quantitated due to
potential phenotype variation. By contrast, the predominantly cell-
surface expression of PDGFRß in S-TGC in Cited2þ /þ (not shown),
Cited2ΔlacZ/þ(Fig. 9A–C) and Tpbpa-Cre conditionally deleted
(Fig. 9J–L) placentas was replaced by a low level cytoplasmic
expression in Cited2ΔlacZ/ΔlacZ (Fig. 9D–F) and Cyp19-Cre (Fig. 9M–
O) conditionally deleted placentas. Tek-Cre conditionally deleted
placentas had an intermediate phenotype with 2/4 placentas
similar to Cited2ΔlacZ/ΔlacZ (not shown) and 2/4 the same as
Cited2þ /þ (Fig. 9G–I). To conﬁrm our observations, we quantiﬁed
PDGFRß staining intensity in S-TGC (deﬁned as non-ACTA2-
expressing cells) in sections from three placentas from each
genotype except Tek-Cre (Fig. S4F). The Tek-Cre placentas were
not quantitated due to variation in phenotype of individual
placentas. These data conﬁrm a slight but signiﬁcant reduction
in PDGFRß protein levels in non-ACTA2-expressing cells from
Cited2ΔlacZ/ΔlacZ and Cyp19-Cre placentas. To compare the expres-
sion levels of PDGFB between E14.5 placentas of all genotypes,
cryosections were stained for PDGFB, PECAM1 and MCT1 (Fig. S9,
magniﬁed views in Figs. 10 and 11). PDGFB expression in Cite-
d2ΔlacZ/ΔlacZ placentas was reduced in VECs, SynT-II cells and S-TGC
(Figs. 10 and 11D–F) compared to Cited2þ /þ (not shown), Cite-
d2ΔlacZ/þ(Figs. 10 and 11A–C) and Tek-Cre (Figs. 10 and 11G–I),
Tpbpa-Cre (Figs. 10 and 11J–L) and Cyp19-Cre (Figs. 10 and 11M–O)
conditionally deleted placentas To analyze further, we quantiﬁed
PDGFB staining intensity in sections from three placentas from
each genotype (Fig. S4G). These data conﬁrm a reduction in mean
PDGFB protein levels in Cited2ΔlacZ/ΔlacZ placentas, however statis-
tical signiﬁcance was not achieved, possibly due to small sample
Fig. 5. Comparison of ß-galactosidase expressing cells with SynT-II cells in Cited2 conditionally deleted placentas. Representative longitudinal parafﬁn sections of (A–D)
Cited2ﬂox/þ; Tek-Creþ , (E–H) Cited2ﬂox/þ; Tpbpa-Creþ and (I–L) Cited2ﬂox/þ; Cyp19-Creþ E14.5 placentas. (A,E,I) ß-galactosidase (white) and MCT4 (green) staining. (B,F,J) The
same sections stained with MCT4 (green), ATPase (red) and Hoechst 33258 (blue). (C,G,K) Merged images. (D,H,L) Schematic representation of the boxed areas in panels D,H,L
showing the basal membrane of the SynT-II layer (green) facing the fetal blood vessels (fbv), sinusoidal TGC (asterisks) and SynT-II nuclei (arrows). Total number of placentas
examined: Tek-Cre n¼4, Tpbpa-Cre n¼4 and Cyp19-Cre n¼4. The scale bar represents 50 μm in immunoﬂuorescence panels and 25 μm in schematic panels.
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size. Thus in Cited2ΔlacZ/ΔlacZ and conditionally deleted placentas
with a capillary phenotype, PDGFRß receptor expression was
altered in trophoblasts, and in Cited2ΔlacZ/ΔlacZ placentas PDGFB
expression was slightly reduced.
Discussion
Complete deletion of Cited2 from the placenta results in abnormal
placental formation and reduced embryonic growth. The labyrinthine
layer of affected placentas has two major phenotypes. Firstly the
capillaries of the embryonic vasculature are abnormally patterned.
Secondly there are fewer capillary-associated pericytes, and those that
remain have disrupted organization. Here we have shown that
conditional deletion of Cited2 from overlapping subsets of cells in
the labyrinthine layer of the placenta using Cyp19-Cre or Tek-Cre
(but not Tpbpa-Cre) can recapitulate the placental phenotype of
Cited2ΔlacZ/ΔlacZ (summarized in Fig. 12). We deduce that Cited2 is
required in the trophectoderm-derived S-TGC and/or syncytiotro-
phoblasts cells for correct patterning of the adjacent embryonic
vasculature. We also provide evidence that this phenotype may
arise via an alteration of PDGF signaling.
Cited2 expression is required in sinusoidal trophoblast giant
cells or syncytiotrophoblasts
Cited2 is expressed in many different types of cell within
the placenta, including both extra-embryonic mesoderm- and
trophectoderm-derived cells and is required for normal placental
development (Withington et al., 2006). We used a conditional
deletion approach to more speciﬁcally deﬁne in which cells Cited2
is required for patterning of the embryonic vasculature and asso-
ciated pericytes. We used three Cre transgenes with overlapping
expression in mesodermal and trophectodermal components of the
placental labyrinth. The capillary and pericyte phenotype was
present in Cyp19-Cre and to a variable extent in Tek-Cre deleted
placentas, but was absent from Tpbpa-Cre deleted placentas. In the
labyrinthine layer, Tpbpa-Cre deleted the Cited2 locus in ACTA2-
positive pericytes, C-TGC and 50% of S-TGC. Since there was no
capillary or pericyte phenotype detected in these placentas, we
conclude that Cited2 is not required in pericytes or C-TGC for the
formation of the embryonic vasculature or pericyte patterning,
migration or proliferation. Secondly, in the labyrinthine layer Tek-
Cre deleted the Cited2 locus from S-TGC, C-TGC, SynT-I and SynT-II
cells. However no ß-galactosidase activity was detectable in the
major site of Tek-Cre expression, VECs. This suggests that Cited2 is
not actively transcribed in VECs. This is contrary to our previous
suggestion based on ß-galactosidase activity from the Cited2ΔlacZ
allele (Withington et al., 2006). However our latest results are more
convincing because we have used co-immunoﬂuorescence and
confocal microscopy to simultaneously visualize ß-galactosidase-
from the Cited2ﬂox allele and IB4 labeled VECs in the same section
(Fig. 3A–D). Therefore we conclude that Cited2 is not required in
VECs for formation of the embryonic vasculature or in pericytes for
pericyte patterning, migration or proliferation. Lastly, Cyp19-Cre
deleted the Cited2 locus from S-TGC, C-TGC, SynT-I and SynT-II cells,
and some pericytes. Taken together with the results from the other
two Cre alleles, we conclude that Cited2 expression in S-TGC or
Fig. 6. Comparison of ß-galactosidase expressing cells with pericytes in Cited2 conditionally deleted placentas. Representative longitudinal parafﬁn sections of (A–D)
Cited2ﬂox/þ; Tek-Creþ , (E–H) Cited2ﬂox/þ; Tpbpa-Creþ and (I–L) Cited2ﬂox/þ; Cyp19-Creþ E14.5 placentas. (A,E,I) ß-galactosidase (red) and DAPI (blue) staining. (B,F,J) The
same sections stained with ACTA2. (C,G,K) Merged images. (D,H,L) Schematic representation of the boxed areas in panels C,G,K with pericytes indicated with arrows. Total
number of placentas examined: Tek-Cre n¼4, Tpbpa-Cre n¼4 and Cyp19-Cre n¼4. The scale bar represents 50 μm in immunoﬂuorescence panels and 13 μm in schematic
panels.
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syncytiotrophoblasts is required for correct patterning of the
embryonic vasculature and/or pericyte recruitment, proliferation
or differentiation.
CITED2 may regulate components of PDGF signaling
PDGF signaling is required for the correct development and
patterning of the vasculature in both embryo and placenta (Leveen
et al., 1994; Ohlsson et al., 1999; Soriano, 1994). Total loss of either
PDGFB ligand or the PDGFRß receptor in mouse results in a similar
capillary and pericyte phenotype in the placenta to that observed
in our study (Ohlsson et al., 1999). PDGF signaling also has a role in
regulating the hematopoietic stem cell niche within the placenta
(Chhabra et al., 2012). Here PDGFB secreted by VECs signals
through PDGFRß in S-TGC to suppress secretion of erythropoeitin
(Epo). Previously, the placental expression pattern of PDGFRß
protein in the mouse has been described in pericytes and S-TGC
(Chhabra et al., 2012; Ohlsson et al., 1999). We conﬁrmed this in
Fig. 7. Conditional deletion of Cited2 in the placenta affects MCT4 expression. Representative longitudinal parafﬁn sections of (A–D) CitedΔlacZ/þ (Het), (E–H) Cited2ΔlacZ/ΔlacZ
(Null), (I–L) Cited2ΔlacZ/ﬂox; Tek-Creþ , (M–P) Cited2ΔlacZ/ﬂox; Tpbpa-Creþ and (Q–T) Cited2ΔlacZ/ﬂox; Cyp19-Creþ E14.5 placentas. A,E,I,M,Q) MCT4 (red) and DAPI (blue) staining.
(B,F,J,N,R) The same sections stained with MCT1 (green) and DAPI (blue) staining. (C,G,K,O,S) Merged images of MCT1, MCT4 and DAPI staining, with magniﬁed views of the
areas boxed in white (D,H,L,P,T respectively). Arrows indicate regions of normal MCT4 staining, and arrowheads indicate regions of altered MCT4 staining. Total number of
placentas examined: Cited2þ /þ (not shown) n¼2, Cited2ΔlacZ/þ n¼3, Cited2ΔlacZ/ΔlacZ n¼4, Tek-Cre n¼4, Tpbpa-Cre n¼4 and Cyp19-Cre n¼4. The scale bar represents 50 μm
in panels A–C, E–G, I–K, M–O, Q–S, and 13 μm in the magniﬁed views (D,H,L,P,T).
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normal placentas (Fig. S7C0 and E0). However, despite dramatic
changes in the number and organization of pericytes in affected
placentas, we did not observe any alteration in the expression of
PDGFRß in these cells (Fig. 8D–F). By contrast, PDGFRß expression
in affected placentas was downregulated in S-TGC (Fig. 9D–F).
Previously it has been reported that PDGFB expression in the
placenta is limited to VECs and some hematopoietic cells (Chhabra
et al., 2012; Ohlsson et al., 1999). We conﬁrmed high levels of
Fig. 8. Conditional deletion of Cited2 in the placenta does not affect PDGFRß expression in pericytes. Longitudinal cryosections of (A–C) Cited2ΔlacZ/þ (Het), (D–F) Cited2ΔlacZ/ΔlacZ
(Null), (G–I) Cited2ΔlacZ/ﬂox; Tek-Creþ , (J–L) Cited2ΔlacZ/ﬂox; Tpbpa-Creþ and (M–O) Cited2ΔlacZ/ﬂox; Cyp19-Creþ E14.5 placentas. (A,D,G.J,M) PDGFRß immunostaining. (B,E,H,K,N)
The same sections stained with ACTA2. (C,F,I,L,O) Merged images showing PDGFRß (green), ACTA2 (red) and DAPI (blue) staining. Pericytes are indicated with arrows and
S-TGC with asterisks. Total number of placentas examined: Cited2þ /þ (not shown) n¼2, Cited2ΔlacZ/þ n¼3, Cited2ΔlacZ/ΔlacZ n¼5, Tek-Cre n¼4, Tpbpa-Cre n¼5 and Cyp19-Cre
n¼5. The scale bar represents 13 μm.
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expression of PDGFB in VECs in normal placentas (Fig. S7H0), but
we also detected signiﬁcant expression of PDGFB in SynT-II and
S-TGC (Fig. S7J0). In Cited2ΔlacZ/ΔlacZ we found slightly reduced
levels of PDGFB in S-TGC, VECs and SynT-II cells (Fig. 10D–F).
Taken together, our results suggest placental pericytes expressing
PDGFRß respond to PDGFB ligand secreted by VECs as well as from
Fig. 9. Conditional deletion of Cited2 in the placenta affects PDGFRß expression in S-TGC and SynT-II. Representative longitudinal cryosections of (A–C) Cited2ΔlacZ/þ(Het),
(D–F) Cited2ΔlacZ/ΔlacZ (Null), (G–I) Cited2ΔlacZ/ﬂox; Tek-Creþ , (J–L) Cited2ΔlacZ/ﬂox; Tpbpa-Creþ and (M–O) Cited2ΔlacZ/ﬂox; Cyp19-Creþ E14.5 placentas. (A,D,G.J,M) PDGFRß
immunostaining. (B,E,H,K,N) The same sections stained with MCT1. (C,F,I,L,O) Merged images showing PDGFRß (green), MCT1 (red) and DAPI (blue) staining. SynT-I cells are
indicated with arrowheads and S-TGC with asterisks. Total number of placentas examined Cited2þ /þ (not shown) n¼2, Cited2ΔlacZ/þ n¼3, Cited2ΔlacZ/ΔlacZ n¼5, Tek-Cre n¼4,
Tpbpa-Cre n¼5 and Cyp19-Cre n¼5. The scale bar represents 13 μM.
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the trophectoderm-derived S-TGC and syncytiotrophoblasts. This
results in the migration, proliferation and differentiation of
pericytes to form the characteristic core-like structures around
which the fetal capillaries are organized. Thus the placental
defect in Cited2ΔlacZ/ΔlacZ and conditionally deleted placentas is
non-cell autonomous, such that loss of Cited2 in S-TGC and/or
Fig. 10. Conditional deletion of Cited2 in the placenta affects PDGFB expression in VECs. Representative longitudinal cryosections of (A–C) Cited2ΔlacZ/þ (Het), (D–F)
Cited2ΔlacZ/ΔlacZ (Null), (G–I) Cited2ΔlacZ/ﬂox; Tek-Creþ , (J–L) Cited2ΔlacZ/ﬂox; Tpbpa-Creþ and (M-O) Cited2ΔlacZ/ﬂox; Cyp19-Creþ E14.5 placentas. (A,D,G,J,M) PDGFB
immunostaining. (B,E,H,K,N) The same sections stained with PECAM1. (C,F,I,L,O) Merged images showing PDGFB (green), PECAM1 (red) and DAPI (blue) staining. VECs
indicated by arrows and S-TGC with asterisks. Total number of placentas examined: Cited2þ /þ (not shown) n¼2, Cited2ΔlacZ/þ n¼3, Cited2ΔlacZ/ΔlacZ n¼5, Tek-Cre n¼5, Tpbpa-
Cre n¼5 and Cyp19-Cre n¼5. The scale bar represents 13 μm.
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syncytiotrophoblasts is likely to result in the observed reduction in
pericyte formation through reduced PDGF signaling. In support of
this model, mosaic deletion of PDGFB from 70% of VECs in the
placenta using the Tie1-Cre transgene results in a similar pheno-
type to complete PDGFB deletion (Bjarnegard et al., 2004), with
enlarged maternal and embryonic vessel lumens, and reduced
Fig. 11. Conditional deletion of Cited2 in the placenta affects PDGFB expression in S-TGC and SynT-II. Representative longitudinal cryosections of (A–C) Cited2ΔlacZ/þ (Het),
(D–F) Cited2ΔlacZ/ΔlacZ (Null), (G–I) Cited2ΔlacZ/ﬂox; Tek-Creþ , (J–L) Cited2ΔlacZ/ﬂox; Tpbpa-Creþ and (M–O) Cited2ΔlacZ/ﬂox; Cyp19-Creþ E14.5 placentas. (A,D,G.J,M) PDGFB
immunostaining. (B,E,H,K,N) The same sections stained with MCT1. (C,F,I,L,O) Merged images showing PDGFB (green), MCT1 (red) and DAPI (blue) staining. SynT-I cells are
indicated by arrows and S-TGC with asterisks. Total number of placentas examined: Cited2þ /þ (not shown) n¼2, Cited2ΔlacZ/þ n¼3, Cited2ΔlacZ/ΔlacZ n¼5, Tek-Cre n¼5, Tpbpa-
Cre n¼5 and Cyp19-Cre n¼5. The scale bar represents 13 μm.
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numbers of pericytes. However it should be noted that the efﬁcacy
of the Tie1-Cre transgene was only tested using the R26R reporter
line. As discussed below, the R26R reporter gene may be poorly
expressed in the placenta, and thus in Bjarnegard et al. (2004) Tie1-
Cre may have also deleted PDGFB expression in other cells such as
S-TGC or syncytiotrophoblasts. CITED2 is a transcriptional modulator,
acting by direct binding to other proteins to positively (Braganca
et al., 2003; Chou et al., 2006; Glenn andMaurer, 1999; Qu et al., 2007;
Tien et al., 2004) or negatively (Bhattacharya et al., 1999; Lou et al.,
2011; Wu et al., 2011) alter their transcriptional activity. Therefore
it is possible that the CITED2 protein is acting as a transcriptional
co-activator to regulate Pdgfb and Pdgfrß expression in S-TGC and
syncytiotrophoblasts. Furthermore, it is possible that CITED2 is
part of an autoregulatory loop in S-TGCs. Chhabra et al. (2012)
showed that PDGF signaling suppresses Epo expression in S-TGC.
In the absence of PDGF signaling, Epo levels in S-TGC increase,
triggering ectopic hematopoiesis. Cited2 transcription can be activated
by Epo signaling (Bakker et al., 2007), therefore conditions of reduced
PDGF signaling in S-TGC might be expected to result in increased
CITED2 protein expression. This could suggest that Cited2 has an
additional role downstream of Epo in triggering hematopoiesis.
Indeed it has been shown in mouse that Cited2 is required for
hematopoietic stem cell (HSC) maintenance in both fetal liver
and adult bone marrow (Chen et al., 2007; Du et al., 2012). This
downstream role could also explain why we do not see an obvious
increase in numbers of hematopoietic stem cells in placentas lacking
Cited2, despite their reduced PDGFRß protein expression. Finally, it is
interesting to note that S-TGCs express high levels of both PDGFRß
and PDGFB. S-TGCs are secretory cells that produce other growth
factors including placental lactogen II (Simmons et al., 2008). This
might suggest there is an as yet unidentiﬁed cell autonomous role
of PDGF signaling in S-TGC proliferation, migration or patterning.
For example, PDGF signaling might be required for the recruitment
of S-TGC to line the maternal sinuses, in a manner analogous to the
recruitment of pericytes to the embryonic vasculature.
Loss of Cited2 may cause reduced embryonic lactate levels
and reduced embryonic growth
Embryo weight was signiﬁcantly reduced in Cited2ΔlacZ/ΔlacZ and
conditionally deleted conceptuses. This suggests that the observed
placental phenotype culminated in placental insufﬁciency. Deletion
of Cited2 in the placenta lead to a loss of MCT4 cell-surface
expression in SynT-II cells, whereas GLUT1 expression in SynT-II cells
and MCT1 expression in SynT-I cells was unaffected. MCT1 and MCT4
are the major lactate transporters expressed in the murine placenta
while GLUT1 is a glucose transporter (Nagai et al., 2010). In the
mouse, the embryonic circulation is high in lactate and maternal
circulation is low in lactate, therefore these proteins may facilitate
transport from mother to embryo (Nagai et al., 2010). Lactate in the
embryo can be used for both fatty acid synthesis and as a metabolic
energy source. Therefore the loss of cell-surface expression of MCT4
may well result in reduced embryonic blood lactate, and be at least
partially responsible for the observed reduction in embryonic
growth. However it would be technically challenging to accurately
measure blood lactate levels in mid-gestation mouse embryos to
prove this hypothesis. Alternatively, this issue could be addressed by
investigation of the placental phenotype of embryos with targeted
deletion of MCT4. The observed differences in severity of placental
phenotype (i.e. poor vascular patterning and fewer and disorganized
pericytes) at E14.5 are likely to be reﬂected in the differences in the
time of onset of reduced placental weight (Fig. 2). Cited2ΔlacZ/ΔlacZ has
signiﬁcantly lighter placental weights from E12.5; the Cyp19-Cre
deleted placentas from E14.5; but the Tek-Cre and Tpbpa-Cre deleted
placentas are not signiﬁcantly smaller until E16.5.
The Cited2ﬂox allele is more broadly deleted than the R26R allele using
the same Cre transgene
In the course of these studies, we determined unexpected
differences between the extent of Cited2ﬂox and Z/EG reporter gene
deletion and that previously published using the same Cre transgenes
but a different reporter gene (R26R). There are two possible explana-
tions for these observations. Firstly, the Cited2ﬂox and Z/EG alleles may
be more readily deleted than the R26R allele. Distinct deletion
efﬁciencies between different ﬂoxed alleles have been previously
reported (Vooijs et al., 2001), and may reﬂect differences in chroma-
tin state between loci that might impede access of Cre protein to the
loxP sites. Alternatively, the Cited2 and pCAGGS promoters may
activate transcription more strongly and/or in a greater proportion
of placental cells than the R26R promoter. Our ﬁndings are an
important lesson for all conditional deletion studies. It emphasizes
Fig. 12. Summary of results of conditional deletion of Cited2 in the placenta. Schematic representation of the cellular organization in the labyrinthine layer of the placenta.
The fetal blood vessels (FBV) contain nucleated embryonic blood cells (ebc; gray), are lined with vascular endothelial cells (VEC; gray) and are organized around cores of
pericytes (PC, pink). The maternal sinusoids (MS) contain enucleated maternal blood cells (mbc; red) and are lined with sinusoidal trophoblast giant cells (S-TGC; yellow). In-
between the VECs and S-TGC are two layers of syncytiotrophoblasts, with the SynT-I layer (blue) immediately adjacent to the S-TGC layer, and the SynT-II layer (green)
immediately adjacent to the VEC layer. (B) Summary of the cells in which Cited2, MCT1, MCT4, PDGFRß and PDGFB are expressed; the cells in which the Cited2ﬂox allele is
deleted for each Cre allele; and the placental phenotype of each deletion allele.
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the need for careful conﬁrmation of the extent of deletion using any
particular combination of ﬂoxed and Cre alleles, rather than relying
on published studies of different tissues to those being investigated.
In addition, these results may suggest a re-evaluation of the conclu-
sions of other studies where deletion of a gene in the placenta has
been performed using one or more of these Cre transgenes.
In conclusion, we believe that Cited2 has an important role in
the patterning of the developing embryonic vasculature of the
placenta. This involves a non-cell autonomous action on pericyte
recruitment, proliferation and/or differentiation, and is most likely
to be mediated by regulation of PDGF signaling. Interestingly, in
this and previous (Withington et al., 2006) studies we have shown
that only the embryonic capillaries of the placenta, and not the
large- or medium-sized placental vessels, are affected by total or
partial loss of placental Cited2 expression. A similar result has
recently been reported for the embryonic vasculature: deletion of
a different Cited2ﬂox allele from all cardiac progenitors using a
heart-speciﬁc Nkx2-5-Cre allele disrupted the patterning of cor-
onary vessels (MacDonald et al., 2013). Here too the number of
large vessels was unchanged, but there were almost half the
number of capillaries present. This suggests that Cited2 may have
a broader role in regulating capillary patterning throughout the
developing conceptus.
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